全文获取类型
收费全文 | 33369篇 |
免费 | 1879篇 |
国内免费 | 175篇 |
专业分类
耳鼻咽喉 | 438篇 |
儿科学 | 707篇 |
妇产科学 | 740篇 |
基础医学 | 4242篇 |
口腔科学 | 1678篇 |
临床医学 | 2457篇 |
内科学 | 8623篇 |
皮肤病学 | 848篇 |
神经病学 | 2616篇 |
特种医学 | 656篇 |
外科学 | 5510篇 |
综合类 | 227篇 |
一般理论 | 4篇 |
预防医学 | 2307篇 |
眼科学 | 607篇 |
药学 | 1880篇 |
中国医学 | 139篇 |
肿瘤学 | 1744篇 |
出版年
2023年 | 254篇 |
2022年 | 204篇 |
2021年 | 1143篇 |
2020年 | 632篇 |
2019年 | 1214篇 |
2018年 | 1376篇 |
2017年 | 806篇 |
2016年 | 845篇 |
2015年 | 1032篇 |
2014年 | 1508篇 |
2013年 | 1808篇 |
2012年 | 2883篇 |
2011年 | 2946篇 |
2010年 | 1691篇 |
2009年 | 1458篇 |
2008年 | 2252篇 |
2007年 | 2317篇 |
2006年 | 2097篇 |
2005年 | 1854篇 |
2004年 | 1731篇 |
2003年 | 1566篇 |
2002年 | 1446篇 |
2001年 | 212篇 |
2000年 | 185篇 |
1999年 | 215篇 |
1998年 | 172篇 |
1997年 | 152篇 |
1996年 | 118篇 |
1995年 | 139篇 |
1994年 | 107篇 |
1993年 | 98篇 |
1992年 | 88篇 |
1991年 | 72篇 |
1990年 | 74篇 |
1989年 | 54篇 |
1988年 | 56篇 |
1987年 | 46篇 |
1986年 | 36篇 |
1985年 | 47篇 |
1984年 | 40篇 |
1983年 | 43篇 |
1982年 | 50篇 |
1981年 | 45篇 |
1980年 | 42篇 |
1979年 | 21篇 |
1978年 | 25篇 |
1977年 | 27篇 |
1976年 | 20篇 |
1975年 | 27篇 |
1974年 | 23篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
11.
Leopoldo Pérez de Isla Raquel Arroyo-Olivares Ovidio Muñiz-Grijalvo José Luis Diaz-Díaz Daniel Zambón Francisco Fuentes Juan F. Sánchez Muñoz-Torrero Juan Diego Mediavilla Aurora González-Estrada Jose Pablo Miramontes-González Raimundo de Andrés Marta Mauri Daniel Mosquera José M. Cepeda Lorena Suárez Miguel Ángel Barba-Romero Rosa Argüeso Pilar Álvarez-Baños Pedro Mata 《Journal of clinical lipidology》2019,13(6):989-996
12.
13.
14.
15.
16.
Jose Luis Górriz Francesc Xavier Cos Claramunt Natalia Duque Arantxa Matali 《Primary Care Diabetes》2019,13(6):485-494
Chronic kidney disease (CKD) is one of the most common complications of type 2 diabetes mellitus (T2DM). Furthermore, CKD confers a considerable increase in the risk of cardiovascular (CV) morbidity and mortality. In line with the need to improve knowledge in this field, this article aims to describe the renal endpoints used in the different cardiovascular outcome trials (CVOTs). The objective is to better know the renal variables used in the different CVOTs in order to optimize the implementation of advances in the prevention of progressive diabetic kidney disease in patients with T2DM in clinical practice. 相似文献
17.
18.
Samira Marín-Romero Teresa Elías-Hernández María Isabel Asensio-Cruz Rocío Ortega-Rivera Raquel Morillo-Guerrero Javier Toral Emilio Montero Verónica Sánchez Elena Arellano José María Sánchez-Díaz Macarena Real-Domínguez Remedios Otero-Candelera Luis Jara-Palomares 《Archivos de bronconeumología》2019,55(12):619-626
IntroductionScales for predicting venous thromboembolism (VTE) recurrence are useful for deciding the duration of the anticoagulant treatment. Although there are several scales, the most appropriate for our setting has not been identified. For this reason, we aimed to validate the DASH prediction score and the Vienna nomogram at 12 months.MethodsThis was a retrospective study of unselected consecutive VTE patients seen between 2006 and 2014. We compared the ability of the DASH score and the Vienna nomogram to predict recurrences of VTE. The validation was performed by stratifying patients as low-risk or high-risk, according to each scale (discrimination) and comparing the observed recurrence with the expected rate (calibration).ResultsOf 353 patients evaluated, 195 were analyzed, with an average age of 53.5 ± 19 years. There were 21 recurrences in 1 year (10.8%, 95% CI: 6.8%-16%). According to the DASH score, 42% were classified as low risk, and the rate of VTE recurrence in this group was 4.9% (95% CI: 1.3%-12%) vs. the high-risk group that was 15% (95% CI: 9%-23%) (p <.05). According to the Vienna nomogram, 30% were classified as low risk, and the rate of VTE recurrence in the low risk group vs. the high risk group was 4.2% (95% CI:0.5%-14%) vs. 16.2% (95% CI: 9.9%-24.4%) (p <.05).ConclusionsOur study validates the DASH score and the Vienna nomogram in our population. The DASH prediction score may be the most advisable, both because of its simplicity and its ability to identify more low-risk patients than the Vienna nomogram (42% vs. 30%). 相似文献
19.
20.